BRAWN BIOTECH LTD. Share Price

Brawn Biotech Limited is an India-based integrated healthcare company. The Company's pharmaceutical products cover all product segments, such as Antibacterials, Cardiovasculars, Antidiabetics, Analgesics, Gastrointestinal, Antifungals, Skin Care, Antipsychotics, Antiasthmatics, Antacids, Antimalarials, And Nutritionals. Its products include Sefix-400 Capsules, Sefix-200 Capsules, Celevran Cream W/C (25GM), Voltran Gel W/C (25GM), Folic Acid Tablets 8P 5MG, Ponstran Capsules 250MG, Fugeran Cream W/C (15GM), Stopin Tablets, Cefixime Tablets 100MG (110), Cefixime Tablets USP 200MG (110), Carbramazepine 200 MG IP Tab, Potassium Chloride for Injection 15% 150mg/ml USP (10 ML), Promethazine HCL Injection 25 MG/ML, Allopurinol 100mg IP Tab, Carbamazepine 100 mg IP Tab, Feme Tab, Bromex Liquid, Salbutamol 4 mg IP Tab, Chlorpheniramine Maleate 4mg Tab, Pheniramine Maleate 25mg Tab, Eracef 500 mg, Erazide 1 Gm Injection, Hyoscine Butyl Bromide (1 ml) IP Inj, Alprazolam 0.5 Mg Tab, and others.As of 26 May 2026, BRAWN BIOTECH LTD. share price is ₹20.13. The stock opened at ₹20.50, compared to its previous close of ₹20.55. During today's trading session, BRAWN BIOTECH LTD. share price moved in the range of ₹20.13 to ₹20.50, with an average price of ₹20.31 for the day. Looking at its last 52-week, the stock has touched a low of ₹20.13 and a high of ₹20.50.

The market capitalization of BRAWN BIOTECH LTD. is ₹6 Crs, with a P/E ratio of -44.7 and a dividend yield of 0.00%.